{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:15:34Z","timestamp":1783041334041,"version":"3.54.6"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SERB-SURE","award":["SUR\/2022\/005296"],"award-info":[{"award-number":["SUR\/2022\/005296"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48239-2","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:45:48Z","timestamp":1777722348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LigGen\u2014a GEN-AI based ligand generation approach for de-novo drug design"],"prefix":"10.1038","volume":"16","author":[{"given":"Anshul","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natarajan Arul","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"48239_CR1","doi-asserted-by":"publisher","unstructured":"Hamet, P. & Tremblay, J. Artificial intelligence in medicine. Metabol. Clin. Exp. 69S, S36\u2013S40.  https:\/\/doi.org\/10.1016\/j.metabol.2017.01.011 (2017).","DOI":"10.1016\/j.metabol.2017.01.011"},{"issue":"4","key":"48239_CR2","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/ijms22041676","volume":"22","author":"VD Mouchlis","year":"2021","unstructured":"Mouchlis, V. D. et al. Advances in de novo drug design: from conventional to machine learning methods. Int. J. Mol. Sci. 22(4), 1676. https:\/\/doi.org\/10.3390\/ijms22041676 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"48239_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1021\/acsmedchemlett.3c00021","volume":"14","author":"A Neumann","year":"2023","unstructured":"Neumann, A., Marrison, L. & Klein, R. Relevance of the trillion-sized chemical space \u201ceXplore\u2019\u2019 as a source for drug discovery. ACS Med. Chem. Lett. 14(4), 466\u2013472 (2023).","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"48239_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1021\/ci100350u","volume":"51","author":"Y Yuan","year":"2011","unstructured":"Yuan, Y., Pei, J. & Lai, L. LigBuilder 2: a practical de novo drug design approach. J. Chem. Inf. Model. 51(5), 1083\u20131091. https:\/\/doi.org\/10.1021\/ci100350u (2011).","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"48239_CR5","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1021\/acs.jmedchem.5b01849","volume":"59","author":"P Schneider","year":"2016","unstructured":"Schneider, P. & Schneider, G. De novo design at the edge of chaos. J. Med. Chem. 59(9), 4077\u20134086. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01849 (2016).","journal-title":"J. Med. Chem."},{"issue":"9","key":"48239_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrd.2016.109","volume":"15","author":"DA Erlanson","year":"2016","unstructured":"Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W. & Jhoti, H. Twenty years on: the impact of fragments on drug discovery. Nat. Rev. Drug Discov. 15(9), 605\u2013619. https:\/\/doi.org\/10.1038\/nrd.2016.109 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"48239_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrd3926-c1","volume":"12","author":"H Jhoti","year":"2013","unstructured":"Jhoti, H., Williams, G., Rees, D. C. & Murray, C. W. The \u2018rule of three\u2019 for fragment-based drug discovery: where are we now?. Nat. Rev. Drug Discov. 12(8), 644\u2013645. https:\/\/doi.org\/10.1038\/nrd3926-c1 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"48239_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tips.2021.04.001","volume":"42","author":"ZZ Wang","year":"2021","unstructured":"Wang, Z. Z., Shi, X. X., Huang, G. Y., Hao, G. F. & Yang, G. F. Fragment-based drug design facilitates selective kinase inhibitor discovery. Trends Pharmacol. Sci. 42(7), 551\u2013565. https:\/\/doi.org\/10.1016\/j.tips.2021.04.001 (2021).","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"48239_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/BF00123669","volume":"8","author":"HJ B\u00f6hm","year":"1994","unstructured":"B\u00f6hm, H. J. On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure. J. Comput.-Aided Mol. Design. 8(5), 623\u2013632. https:\/\/doi.org\/10.1007\/BF00123669 (1994).","journal-title":"J. Comput.-Aided Mol. Design."},{"key":"48239_CR10","unstructured":"Inte:Ligand - Products \u2014 inteligand.com.   https:\/\/www.inteligand.com\/products\/ (2025)."},{"issue":"18","key":"48239_CR11","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1021\/jm9706776","volume":"41","author":"J Sadowski","year":"1998","unstructured":"Sadowski, J. & Kubinyi, H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 41(18), 3325\u20133329. https:\/\/doi.org\/10.1021\/jm9706776 (1998).","journal-title":"J. Med. Chem."},{"issue":"3","key":"48239_CR12","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1073\/pnas.032673399","volume":"99","author":"BA Grzybowski","year":"2002","unstructured":"Grzybowski, B. A. et al. Combinatorial computational method gives new picomolar ligands for a known enzyme. Proc. Natl. Acad. Sci. 99(3), 1270\u20131273. https:\/\/doi.org\/10.1073\/pnas.032673399 (2002).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"48239_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fchem.2020.00142","volume":"8","author":"Y Yuan","year":"2020","unstructured":"Yuan, Y., Pei, J. & Lai, L. LigBuilder V3: a multi-target de novo drug design approach. Front. Chem. 8, 142. https:\/\/doi.org\/10.3389\/fchem.2020.00142 (2020).","journal-title":"Front. Chem."},{"issue":"47","key":"48239_CR14","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1021\/acs.biochem.5b00820","volume":"54","author":"CJ Yang","year":"2015","unstructured":"Yang, C. J., Takeda, M., Terauchi, T., Jee, J. & Kainosho, M. Differential large-amplitude breathing motions in the interface of FKBP12-drug complexes. Biochemistry. 54(47), 6983\u20136995. https:\/\/doi.org\/10.1021\/acs.biochem.5b00820 (2015).","journal-title":"Biochemistry"},{"issue":"14","key":"48239_CR15","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1021\/jm000017s","volume":"43","author":"HJ Boehm","year":"2000","unstructured":"Boehm, H. J. et al. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J. Med. Chem. 43(14), 2664\u20132674. https:\/\/doi.org\/10.1021\/jm000017s (2000).","journal-title":"J. Med. Chem."},{"issue":"1","key":"48239_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/a:1008040531766","volume":"13","author":"HJ B\u00f6hm","year":"1999","unstructured":"B\u00f6hm, H. J., Banner, D. W. & Weber, L. Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors. J. Comput.-Aided Mol. Design. 13(1), 51\u201356. https:\/\/doi.org\/10.1023\/a:1008040531766 (1999).","journal-title":"J. Comput.-Aided Mol. Design."},{"issue":"1","key":"48239_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bmcl.2005.09.045","volume":"16","author":"T Heikkil\u00e4","year":"2006","unstructured":"Heikkil\u00e4, T. et al. The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. Bioorg. Med. Chem. Lett. 16(1), 88\u201392. https:\/\/doi.org\/10.1016\/j.bmcl.2005.09.045 (2006).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"48239_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","volume":"4","author":"MHS Segler","year":"2018","unstructured":"Segler, M. H. S., Kogej, T., Tyrchan, C. & Waller, M. P. Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS Central Sci. 4(1), 120\u2013131. https:\/\/doi.org\/10.1021\/acscentsci.7b00512 (2018).","journal-title":"ACS Central Sci."},{"issue":"2","key":"48239_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","volume":"4","author":"R G\u00f3mez-Bombarelli","year":"2018","unstructured":"G\u00f3mez-Bombarelli, R. et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Central Sci. 4(2), 268\u2013276. https:\/\/doi.org\/10.1021\/acscentsci.7b00572 (2018).","journal-title":"ACS Central Sci."},{"issue":"1\u20132","key":"48239_CR20","doi-asserted-by":"publisher","first-page":"1700111","DOI":"10.1002\/minf.201700111","volume":"37","author":"A Gupta","year":"2018","unstructured":"Gupta, A. et al. Generative recurrent networks for de novo drug design. Mol. Inf. 37(1\u20132), 1700111. https:\/\/doi.org\/10.1002\/minf.201700111 (2018).","journal-title":"Mol. Inf."},{"issue":"1","key":"48239_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13321-017-0235-x","volume":"9","author":"M Olivecrona","year":"2017","unstructured":"Olivecrona, M., Blaschke, T., Engkvist, O. & Chen, H. Molecular de-novo design through deep reinforcement learning. J. Cheminform. 9(1), 48. https:\/\/doi.org\/10.1186\/s13321-017-0235-x (2017).","journal-title":"J. Cheminform."},{"key":"48239_CR22","unstructured":"Peng, X., Luo, S., Guan, J., Xie, Q., Peng, J. & Ma, J. Pocket2Mol: efficient molecular sampling based on 3D protein pockets. arXiv. ArXiv:2205.07249 [cs, q-bio]. http:\/\/arxiv.org\/abs\/2205.07249 (2025)."},{"issue":"24","key":"48239_CR23","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1021\/jacs.8b02118","volume":"140","author":"V Scutelnic","year":"2018","unstructured":"Scutelnic, V. et al. The structure of the protonated serine octamer. J. Am. Chem. Soc. 140(24), 7554\u20137560. https:\/\/doi.org\/10.1021\/jacs.8b02118 (2018).","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"48239_CR24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1021\/acsomega.3c07600","volume":"9","author":"M Roth","year":"2024","unstructured":"Roth, M., Toker, Y. & Major, D. T. Monte Carlo-simulated annealing and machine learning-based funneled approach for finding the global minimum structure of molecular clusters. ACS omega. 9(1), 1298\u20131309. https:\/\/doi.org\/10.1021\/acsomega.3c07600 (2024).","journal-title":"ACS omega"},{"key":"48239_CR25","doi-asserted-by":"publisher","unstructured":"Krenn, M., H\u00e4se, F., Nigam, A., Friederich, P. & Aspuru-Guzik, A. Self-referencing embedded strings (SELFIES): a 100% robust molecular string representation. Mach. Learn. Sci. Technol. 1 (4), 045024.  https:\/\/doi.org\/10.1088\/2632-2153\/aba947. (2020)","DOI":"10.1088\/2632-2153\/aba947"},{"key":"48239_CR26","doi-asserted-by":"publisher","unstructured":"Chung, J., Gulcehre, C., Cho, K. & Bengio Y. Empirical evaluation of gated recurrent neural networks on sequence modeling.  arXiv:1412.3555. https:\/\/doi.org\/10.48550\/arXiv.1412.3555 (2014).","DOI":"10.48550\/arXiv.1412.3555"},{"key":"48239_CR27","unstructured":"RDKit \u2014 rdkit.org.  https:\/\/www.rdkit.org\/ (2025)."},{"issue":"1","key":"48239_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl, P. & Schuffenhauer, A. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform. 1(1), 8. https:\/\/doi.org\/10.1186\/1758-2946-1-8 (2009).","journal-title":"J. Cheminform."},{"issue":"8","key":"48239_CR29","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model. 61(8), 3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"48239_CR30","unstructured":"Fletcher, R. Practical Methods of Optimization (Wiley, 2013). Google-Books-ID: _WuAvIx0EE4C."},{"key":"48239_CR31","doi-asserted-by":"publisher","unstructured":"Numerical Optimization. Springer Series in Operations Research and Financial Engineering (Springer, 2006).  https:\/\/doi.org\/10.1007\/978-0-387-40065-5.","DOI":"10.1007\/978-0-387-40065-5"},{"key":"48239_CR32","unstructured":"Brownlee, J. A gentle introduction to the BFGS optimization algorithm.  https:\/\/machinelearningmastery.com\/bfgs-optimization-in-python\/ (2025)."},{"issue":"suppl-1","key":"48239_CR33","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34(suppl-1), D668\u2013D672. https:\/\/doi.org\/10.1093\/nar\/gkj067 (2006).","journal-title":"Nucleic Acids Res."},{"key":"48239_CR34","unstructured":"Daylight>Products.  https:\/\/www.daylight.com\/products\/wdi.html (2025)."},{"issue":"9","key":"48239_CR35","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/bioinformatics\/bti295","volume":"21","author":"A Goede","year":"2005","unstructured":"Goede, A., Dunkel, M., Mester, N., Frommel, C. & Preissner, R. SuperDrug: a conformational drug database. Bioinformatics 21(9), 1751\u20131753. https:\/\/doi.org\/10.1093\/bioinformatics\/bti295 (2005).","journal-title":"Bioinformatics"},{"key":"48239_CR36","unstructured":"Fu, C., Li, X., Olson, B., Ji, H., & Ji, S. Fragment and geometry aware Tokenization of molecules for structure-based drug design using language models. arXiv. ArXiv:2408.09730.   http:\/\/arxiv.org\/abs\/2408.09730 (2025)."},{"key":"48239_CR37","unstructured":"Luo, S., Guan, J., Ma, J. & Peng, J. A 3D gnerative model for structure-based drug design. In  Advances in Neural Information Processing Systems 6229\u20136239  (Curran Associates, Inc., 2021).  https:\/\/proceedings.neurips.cc\/paper\/2021\/hash\/314450613369e0ee72d0da7f6fee773c-Abstract.html."},{"key":"48239_CR38","unstructured":"Liu, M., Luo, Y., Uchino, K., Maruhashi, K. & Ji, S. Generating 3D molecules for target protein binding. In Proceedings of the 39th International Conference on Machine Learning   13912\u201313924 (PMLR, 2022).  https:\/\/proceedings.mlr.press\/v162\/liu22m.html."},{"key":"48239_CR39","unstructured":"Guan, J., Qian, W. W., Peng, X., Su, Y., Peng, J. & Ma, J. 3D equivariant diffusion for target-aware molecule generation and affinity prediction.   Available from: https:\/\/openreview.net\/forum?id=kJqXEPXMsE0 (2022)."},{"key":"48239_CR40","unstructured":"Guan, J.  et al. DECOMPDIFF: diffusion models with decomposed priors for structure-based drug design. In Proceedings of the 40th International Conference on Machine Learning. vol. 202 of ICML\u201923. Honolulu, Hawaii, USA  JMLR.org  11827\u201311846   (2023)."},{"issue":"12","key":"48239_CR41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s43588-024-00737-x","volume":"4","author":"A Schneuing","year":"2024","unstructured":"Schneuing, A. et al. Structure-based drug design with equivariant diffusion models. Nat. Comput. Sci. 4(12), 899\u2013909. https:\/\/doi.org\/10.1038\/s43588-024-00737-x (2024).","journal-title":"Nat. Comput. Sci."},{"key":"48239_CR42","unstructured":"Zhang, Z., Min, Y., Zheng, S. & Liu, Q. Molecule generation for target protein bnding with structural motifs. https:\/\/openreview.net\/forum?id=Rq13idF0F73 (2022)."},{"key":"48239_CR43","unstructured":"Zhang, Z. & Liu, Q. Learning subpocket prototypes for generalizable structure-based drug design. In Proceedings of the 40th International Conference on Machine Learning. vol. 202 of ICML\u201923. Honolulu, Hawaii, USA  JMLR.org  41382\u201341398 (2023)."},{"key":"48239_CR44","doi-asserted-by":"publisher","unstructured":"Feng, W.  et al. Generation of 3D molecules in pockets via a language model. Nat. Mach. Intell. 6 (1), 62\u201373.  https:\/\/doi.org\/10.1038\/s42256-023-00775-6 (2024).","DOI":"10.1038\/s42256-023-00775-6"},{"issue":"13","key":"48239_CR45","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/bioinformatics\/btv082","volume":"31","author":"A Alhossary","year":"2015","unstructured":"Alhossary, A., Handoko, S. D., Mu, Y. & Kwoh, C. K. Fast, accurate, and reliable molecular docking with QuickVina 2. Bioinformatics 31(13), 2214\u20132216. https:\/\/doi.org\/10.1093\/bioinformatics\/btv082 (2015).","journal-title":"Bioinformatics"},{"issue":"10","key":"48239_CR46","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51(10), 2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u (2011).","journal-title":"J. Chem. Inf. Model."},{"key":"48239_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-024-00812-5","author":"HH Loeffler","year":"2024","unstructured":"Loeffler, H. H. et al. Reinvent 4: modern AI-driven generative molecule design. J. Cheminform. https:\/\/doi.org\/10.1186\/s13321-024-00812-5 (2024).","journal-title":"J. Cheminform."},{"key":"48239_CR48","unstructured":"Bank RPD.: RCSB PDB - 2G94: crystal structure of beta-secretase bound to a potent and highly selective inhibitor.  https:\/\/www.rcsb.org\/structure\/2G94  (2025)."},{"key":"48239_CR49","unstructured":"Bank RPD.: RCSB PDB - 2V5Z: structure of human MAO B in complex with the selective inhibitor safinamide.  https:\/\/www.rcsb.org\/structure\/2v5z  (2025)."},{"key":"48239_CR50","unstructured":"Bank RPD: RCSB PDB - 7D9O: crystal structure of recombinant human acetylcholinesterase in cmplex with compound 2.  https:\/\/www.rcsb.org\/structure\/7D9O (2025)."},{"issue":"16","key":"48239_CR51","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1021\/ja058636j","volume":"128","author":"AK Ghosh","year":"2006","unstructured":"Ghosh, A. K. et al. Design, synthesis and X-ray structure of protein-ligand complexes: important insight into selectivity of memapsin 2 ($$\\beta$$-secretase) inhibitors. J. Am. Chem. Soc. 128(16), 5310\u20135311. https:\/\/doi.org\/10.1021\/ja058636j (2006).","journal-title":"J. Am. Chem. Soc."},{"issue":"23","key":"48239_CR52","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"C Binda","year":"2007","unstructured":"Binda, C. et al. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J. Med. Chem. 50(23), 5848\u20135852. https:\/\/doi.org\/10.1021\/jm070677y (2007).","journal-title":"J. Med. Chem."},{"issue":"4","key":"48239_CR53","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1021\/acs.jmedchem.0c01863","volume":"64","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Kinetics-driven drug design strategy for next-generation acetylcholinesterase inhibitors to Clinical candidate. J. Med. Chem. 64(4), 1844\u20131855. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01863 (2021).","journal-title":"J. Med. Chem."},{"issue":"10","key":"48239_CR54","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A. & Moreno, E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 17(10), 6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"48239_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 1\u20132, 19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","journal-title":"SoftwareX."},{"issue":"3","key":"48239_CR56","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak, V. et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Struct. Funct. Bioinform. 65(3), 712\u2013725. https:\/\/doi.org\/10.1002\/prot.21123 (2006).","journal-title":"Proteins: Struct. Funct. Bioinform."},{"issue":"9","key":"48239_CR57","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25(9), 1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035 (2004).","journal-title":"J. Comput. Chem."},{"key":"48239_CR58","unstructured":"Yadav, A. & Murugan, N. A. LigGen web server.  https:\/\/neurocare-liggen.iiitd.edu.in\/  (2025)."},{"key":"48239_CR59","unstructured":"Yadav, A. & Murugan, N. A. LigGen tool and datasets. Zenodo.  https:\/\/zenodo.org\/records\/17733479?token=eyJhbGciOiJIUzUxMiJ9.eyJpZCI6IjVmODEyNTVjLTdhN2QtNDg3Zi1iM2VjLWU3ODBjNWQzMWM1MiIsImRhdGEiOnt9LCJyYW5kb20iOiIyYjUxN2E5OWVmMmZiMGYxZjA3NDkzMmVhMTQ1NzMyZSJ9.7RipTf6rSuFlEvaf0ffFY6k7FPgB26s2au6I3KIaAXs1YuBqB9Rv9rOohZpgwtTvef43JMs1Kz9kYWHH-A8QzQ (2025)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48239-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48239-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48239-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:19:08Z","timestamp":1783037948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48239-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48239"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48239-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20477"}}